Insider Buying: Microba Life Sciences Limited (ASX:MAP) Insider Acquires 200,000 Shares of Stock

Microba Life Sciences Limited (ASX:MAP) insider Pasquale (Paddy) Rombola acquired 200,000 shares of the firm’s stock in a transaction on Tuesday, November 19th. The stock was purchased at an average cost of A$0.17 ($0.11) per share, with a total value of A$34,200.00 ($22,207.79).

Microba Life Sciences Price Performance

The company has a current ratio of 2.61, a quick ratio of 6.50 and a debt-to-equity ratio of 3.84.

Microba Life Sciences Company Profile

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.